Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Angiotensin II type 1 receptor antibodies in childhood kidney transplantation

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
211kB

Item Type:Article
Title:Angiotensin II type 1 receptor antibodies in childhood kidney transplantation
Creators Name:Bjerre, A. and Tangeraas, T. and Heidecke, H. and Dragun, D. and Dechend, R. and Staff, A.C.
Abstract:Angiotensin II type 1 receptor antibodies (AT1 RAb) have emerged as non-HLA Ab present in patients with acute AMR and risk of graft loss. Furthermore, AT1 RAb have been shown to increase angiotensin II sensitivity which may play a role in the development of CVD and hypertension. Data on AT1 RAb in stable transplant recipients are lacking. The aim of this study was to analyze the levels of AT1 RAb in a cohort of stable patients after kidney transplantation (tx) in childhood. A cross-sectional study of 30 children (median age 14, range 3-19 yr, median time since tx five yr) and 28 adults who were transplanted in childhood (median age 26, range 20-40 yr, median time since tx 18 yr) transplanted between 1993-2006 and 1983-2002, respectively, was performed. Healthy controls were 51 healthy children (5-8 yr) and 199 healthy donors (median age 56.5 yr, range 42-83 yr). Plasma AT1 RAb were analyzed by immunoassay. Median total AT1 RAb IgG concentration was significantly higher in the pediatric-tx group as compared to the adult-tx group (40.0 and 10.95 U/mL, p < 0.0001). For both groups, the tx group showed higher levels: the pediatric-tx group vs. control group (40.0 vs. 13.3 U/mL, p = 0.0006) and the adult-tx group vs. adult control group (10.95 vs. 6.5 U/mL, p < 0.0001). Age was the strongest indicator of high levels of AT1 RAb IgG (p = 0.0003). AT1 RAb total IgG levels are significantly higher in a stable pediatric-tx cohort as compared to adult-tx patients and healthy controls of comparable age groups. The relevance of our findings in relation to age, time since tx, previous or future rejection, and CVD risk merits future studies.
Keywords:Angiotensin II Type 1 Receptor Antibodies, Rejection, Hypertension, Kidney Transplantation, Children, Cardiovascular Disease
Source:Pediatric Transplantation
ISSN:1397-3142
Publisher:Wiley-Blackwell (U.S.A.)
Volume:20
Number:5
Page Range:627-632
Date:August 2016
Official Publication:https://doi.org/10.1111/petr.12728
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library